Cronos Group Inc(CRON-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low2.60
Day High2.70
Open:2.60
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
GlobeNewswire
Cronos Announces Extension of Share Repurchase Program to the Toronto Stock Exchange
Motley Fool
Better Marijuana Stock to Buy Right Now: Tilray or Trulieve?
GlobeNewswire
Spinach® is the Number One Vape Brand in Canada
Motley Fool
Canopy Growth Is Restating Two Years of Financials Before June 15 Earnings -- Here's What CGC Investors Need to Know Right Now
Tipranks
Analysts Conflicted on These Healthcare Names: Cronos Group (CRON), Savara (SVRA) and Alkermes (ALKS)
Tipranks
Cronos Group Announces New Share Buyback After Strong Quarter
MarketBeat
Cronos Group Q1 Earnings Call Highlights
MarketBeat.com
GlobeNewswire
Cronos Group Reports 2026 First Quarter Results
GlobeNewswire
Cronos Expands Pre-Roll Portfolio with Spinach STIX®
GlobeNewswire
Cronos Group Inc. to Hold Virtual 2026 Annual Meeting of Shareholders
Motley Fool
From $500 to $1: Is Canopy Growth a Dead Stock Walking or the Ultimate Turnaround Play?
GlobeNewswire
Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026
Motley Fool
Forget Tilray: This Boring Dividend Beast Is a Much Savvier Play
Motley Fool
The Major Long-Term Risk Facing Altria Stock in 2026
Zacks Investment Research
Cannabis Operator CRON Rises 46% in a Year: Time to Buy, Sell or Hold?
Cannabis Operator CRON Rises 46% in a Year: Time to Buy, Sell or Hold?
GlobeNewswire
Cronos Group Inc. to Speak at the 38th Annual ROTH Conference
Tipranks
Cronos Group Posts Record 2025 Revenue and Eyes European Cannabis Expansion
GlobeNewswire
Cronos Group Reports 2025 Fourth Quarter and Full-Year Results
GlobeNewswire
Cronos Launches New All-in-One Vape, Spinach PUFFERZ™

Profile

Cronos Group, Inc. engages in the investment in firms which are licensed to produce and sell medical marijuana. Its portfolio includes In The Zone, Peace Naturals, Whistler Medical Marijuana Co., ABcann, Hydropothecary, Vert Medical and Evergreen Medicinal Supply. Cronos Group Inc., formerly known as PharmaCan Capital Corp., is headquartered in Toronto, Canada.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.